(Q47262415)

12 January 2018

title

Weight gain, dyslipidemia and altered parameters for metabolic syndrome on first episode psychotic patients after six-month follow-up (English)

1 reference

12 January 2018

1 reference

1 reference

1 reference

1 reference

Cecília Attux

1

1 reference

12 January 2018

Maria Inês Quintana

series ordinal

2

1 reference

12 January 2018

Ana Cristina Chaves

series ordinal

3

1 reference

12 January 2018

publication date

1 December 2007

1 reference

12 January 2018

Brazilian Journal of Psychiatry

published in

1 reference

12 January 2018

volume

29

1 reference

12 January 2018

issue

4

1 reference

12 January 2018

page(s)

346-349

1 reference

12 January 2018

A review of the effect of atypical antipsychotics on weight

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Gender differences in the metabolic syndrome and their role for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Effect of olanzapine on body composition and energy expenditure in adults with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Gender differences in the prescribing of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Sex selection bias in schizophrenia antipsychotic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Schizophrenia and weight management: a systematic review of interventions to control weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

Comments on "Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine".

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

First-episode schizophrenia: a focus on pharmacological treatment and safety considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462006005000061

10.1590/S1516-44462006005000061

21 January 2018

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018